1834 Investment Advisors Co. cut its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 12.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 22,356 shares of the company's stock after selling 3,230 shares during the quarter. 1834 Investment Advisors Co.'s holdings in Procter & Gamble were worth $3,810,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Unique Wealth LLC increased its stake in shares of Procter & Gamble by 2.9% in the first quarter. Unique Wealth LLC now owns 2,141 shares of the company's stock worth $365,000 after acquiring an additional 61 shares during the last quarter. Stableford Capital II LLC grew its stake in Procter & Gamble by 1.1% in the first quarter. Stableford Capital II LLC now owns 5,817 shares of the company's stock valued at $993,000 after purchasing an additional 61 shares in the last quarter. Bernard Wealth Management Corp. increased its position in Procter & Gamble by 20.2% in the 1st quarter. Bernard Wealth Management Corp. now owns 375 shares of the company's stock worth $64,000 after purchasing an additional 63 shares during the last quarter. B & T Capital Management DBA Alpha Capital Management raised its stake in shares of Procter & Gamble by 2.3% during the 1st quarter. B & T Capital Management DBA Alpha Capital Management now owns 2,795 shares of the company's stock worth $476,000 after purchasing an additional 63 shares in the last quarter. Finally, Kolinsky Wealth Management LLC lifted its holdings in shares of Procter & Gamble by 1.1% during the 4th quarter. Kolinsky Wealth Management LLC now owns 5,738 shares of the company's stock valued at $962,000 after buying an additional 64 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.
Procter & Gamble Stock Performance
PG opened at $152.87 on Thursday. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. The stock's 50 day moving average price is $158.89 and its two-hundred day moving average price is $163.80. The firm has a market capitalization of $358.09 billion, a P/E ratio of 23.48, a price-to-earnings-growth ratio of 3.97 and a beta of 0.37. Procter & Gamble Company has a 12-month low of $149.91 and a 12-month high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%. The company had revenue of $20.89 billion during the quarter, compared to analysts' expectations of $20.79 billion. During the same period in the prior year, the business earned $1.40 earnings per share. Procter & Gamble's revenue for the quarter was up 1.7% compared to the same quarter last year. On average, equities analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be issued a dividend of $1.0568 per share. The ex-dividend date is Friday, July 18th. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. Procter & Gamble's payout ratio is presently 64.98%.
Analysts Set New Price Targets
PG has been the topic of several recent research reports. Piper Sandler raised their price objective on shares of Procter & Gamble from $160.00 to $164.00 and gave the company a "neutral" rating in a research report on Monday, May 5th. Evercore ISI restated an "in-line" rating and set a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Redburn Partners set a $161.00 price objective on shares of Procter & Gamble in a research note on Thursday, May 1st. Royal Bank Of Canada raised shares of Procter & Gamble from a "sector perform" rating to an "outperform" rating and increased their target price for the stock from $164.00 to $177.00 in a research report on Friday, April 25th. Finally, Citigroup reduced their price target on Procter & Gamble from $200.00 to $181.00 and set a "buy" rating for the company in a research report on Friday, April 25th. Seven analysts have rated the stock with a hold rating, ten have issued a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, Procter & Gamble presently has a consensus rating of "Moderate Buy" and a consensus price target of $175.88.
Read Our Latest Research Report on Procter & Gamble
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.